サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1468104

スマートインスリンペンの市場レポート：タイプ、ユーザビリティ、適応症、接続性、エンドユーザー、地域別、2024～2032年

Smart Insulin Pens Market Report by Type, Usability, Indication, Connectivity, End User, and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 138 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
スマートインスリンペンの市場レポート：タイプ、ユーザビリティ、適応症、接続性、エンドユーザー、地域別、2024～2032年
出版日: 2024年04月08日
発行: IMARC
ページ情報: 英文 138 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

スマートインスリンペンの世界市場規模は、2023年に1億3,170万米ドルに達しました。今後、IMARC Groupは、市場は2032年までに3億1,950万米ドルに達し、2024～2032年の間に10％の成長率（CAGR）を示すと予測しています。

スマートインスリンペンは、糖尿病患者のインスリン投与を効率的に管理するためのスマートフォンアプリを備えた再利用可能な注射器ペンです。従来のインスリンと比較して、より手頃な価格で使いやすく、有用なリマインダー、アラート、レポートを記載しています。血糖値、炭水化物量、食事量、活性型インスリンの投与量を計算するのに役立ちます。さらに、インスリンの有効期限や温度範囲超過を通知し、カートリッジをタイムリーに交換することができます。その結果、スマートインスリンペンは、世界中の病院、クリニック、外来手術センター、在宅ケアユニットで広範なアプリケーションを見つけています。

スマートインスリンペンの市場動向：

現在、スマートインスリンペンの利点である、正確な半量投与、飲み忘れや飲み忘れの防止、投与時間や回数の追跡などに関する大衆の意識の高まりは、市場を牽引する重要な要因の1つとなっています。これに加えて、世界中で肥満と高齢者人口の増加により糖尿病の有病率が上昇しています。これは、急成長する医療産業とともに、市場の成長を強化しています。また、主要市場参入企業は、患者にインテリジェントな注射を提供するメモリとタイミング機能を備えたスマートインスリンペンを導入するための研究開発（R&D）活動に幅広く投資しています。また、Bluetooth接続のスマートインスリンペンの開発にも注力しています。さらに、より快適で、便利で、個別化されているため、在宅治療の採用が増加しています。これは、針の使用、取り扱い、分解、または廃棄中に針刺し事故が増加しているため、針を使用しないインスリン送達デバイスの需要が高まっていることと相まって、市場の成長を強化しています。

本レポートで扱う主要質問

  • 2023年のスマートインスリンペンの世界市場規模は？
  • 2024～2032年にかけてのスマートインスリンペンの世界市場の予想成長率は？
  • スマートインスリンペンの世界市場を牽引する主要因は？
  • COVID-19がスマートインスリンペンの世界市場に与えた影響は？
  • スマートインスリンペンの世界市場のタイプ別区分は？
  • ユーザビリティ別のスマートインスリンペンの世界市場の内訳は？
  • エンドユーザー別のスマートインスリンペンの世界市場の内訳は？
  • スマートインスリンペンの世界市場における主要地域は？
  • スマートインスリンペンの世界市場における主要参入企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 スマートインスリンペンの世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：タイプ別

  • 第一世代ペン
  • 第二世代ペン

第7章 市場内訳：ユーザビリティ別

  • プレフィルド
  • 再利用可能

第8章 市場内訳：適応症別

  • 1型糖尿病
  • 2型糖尿病

第9章 市場内訳：接続性別

  • Bluetooth
  • USB

第10章 市場内訳：エンドユーザー別

  • 病院・クリニック
  • 外来手術センター
  • 在宅ケア

第11章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第12章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第13章 バリューチェーン分析

第14章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第15章 価格分析

第16章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Bigfoot Biomedical Inc.
    • Digital Medics Pty Ltd.
    • Emperra GmbH E-Health Technologies
    • Jiangsu Delfu Medical Device Co. Ltd.
    • Medtronic plc
    • Novo Nordisk A/S
    • pendiq GmbH
    • Ypsomed AG
図表

List of Figures

  • Figure 1: Global: Smart Insulin Pens Market: Major Drivers and Challenges
  • Figure 2: Global: Smart Insulin Pens Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Smart Insulin Pens Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: Smart Insulin Pens Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Smart Insulin Pens Market: Breakup by Usability (in %), 2023
  • Figure 6: Global: Smart Insulin Pens Market: Breakup by Indication (in %), 2023
  • Figure 7: Global: Smart Insulin Pens Market: Breakup by Connectivity (in %), 2023
  • Figure 8: Global: Smart Insulin Pens Market: Breakup by End User (in %), 2023
  • Figure 9: Global: Smart Insulin Pens Market: Breakup by Region (in %), 2023
  • Figure 10: Global: Smart Insulin Pens (First Generation Pens) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Smart Insulin Pens (First Generation Pens) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Smart Insulin Pens (Second Generation Pens) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Smart Insulin Pens (Second Generation Pens) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Smart Insulin Pens (Prefilled) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Smart Insulin Pens (Prefilled) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Smart Insulin Pens (Reusable) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Smart Insulin Pens (Reusable) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Smart Insulin Pens (Type 1 Diabetes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Smart Insulin Pens (Type 1 Diabetes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Smart Insulin Pens (Type 2 Diabetes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Smart Insulin Pens (Type 2 Diabetes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Smart Insulin Pens (Bluetooth) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Smart Insulin Pens (Bluetooth) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Smart Insulin Pens (USB) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Smart Insulin Pens (USB) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Smart Insulin Pens (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Smart Insulin Pens (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Smart Insulin Pens (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Smart Insulin Pens (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Smart Insulin Pens (Home Care Settings) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Smart Insulin Pens (Home Care Settings) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: North America: Smart Insulin Pens Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: North America: Smart Insulin Pens Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: United States: Smart Insulin Pens Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: United States: Smart Insulin Pens Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Canada: Smart Insulin Pens Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Canada: Smart Insulin Pens Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Asia-Pacific: Smart Insulin Pens Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Asia-Pacific: Smart Insulin Pens Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: China: Smart Insulin Pens Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: China: Smart Insulin Pens Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Japan: Smart Insulin Pens Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Japan: Smart Insulin Pens Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: India: Smart Insulin Pens Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: India: Smart Insulin Pens Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: South Korea: Smart Insulin Pens Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: South Korea: Smart Insulin Pens Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Australia: Smart Insulin Pens Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Australia: Smart Insulin Pens Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Indonesia: Smart Insulin Pens Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Indonesia: Smart Insulin Pens Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Others: Smart Insulin Pens Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Others: Smart Insulin Pens Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Europe: Smart Insulin Pens Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Europe: Smart Insulin Pens Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Germany: Smart Insulin Pens Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Germany: Smart Insulin Pens Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: France: Smart Insulin Pens Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: France: Smart Insulin Pens Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: United Kingdom: Smart Insulin Pens Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: United Kingdom: Smart Insulin Pens Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Italy: Smart Insulin Pens Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Italy: Smart Insulin Pens Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Spain: Smart Insulin Pens Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Spain: Smart Insulin Pens Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Russia: Smart Insulin Pens Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Russia: Smart Insulin Pens Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Others: Smart Insulin Pens Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Others: Smart Insulin Pens Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Latin America: Smart Insulin Pens Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Latin America: Smart Insulin Pens Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Brazil: Smart Insulin Pens Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Brazil: Smart Insulin Pens Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Mexico: Smart Insulin Pens Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Mexico: Smart Insulin Pens Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Others: Smart Insulin Pens Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Others: Smart Insulin Pens Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Middle East and Africa: Smart Insulin Pens Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Middle East and Africa: Smart Insulin Pens Market: Breakup by Country (in %), 2023
  • Figure 80: Middle East and Africa: Smart Insulin Pens Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Global: Smart Insulin Pens Industry: SWOT Analysis
  • Figure 82: Global: Smart Insulin Pens Industry: Value Chain Analysis
  • Figure 83: Global: Smart Insulin Pens Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Smart Insulin Pens Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Smart Insulin Pens Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Smart Insulin Pens Market Forecast: Breakup by Usability (in Million US$), 2024-2032
  • Table 4: Global: Smart Insulin Pens Market Forecast: Breakup by Indication (in Million US$), 2024-2032
  • Table 5: Global: Smart Insulin Pens Market Forecast: Breakup by Connectivity (in Million US$), 2024-2032
  • Table 6: Global: Smart Insulin Pens Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 7: Global: Smart Insulin Pens Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 8: Global: Smart Insulin Pens Market: Competitive Structure
  • Table 9: Global: Smart Insulin Pens Market: Key Players
目次
Product Code: SR112024A6138

The global smart insulin pens market size reached US$ 131.7 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 319.5 Million by 2032, exhibiting a growth rate (CAGR) of 10% during 2024-2032.

A smart insulin pen is a reusable injector pen with a smartphone app that facilitates patients with diabetes in managing their insulin delivery efficiently. It is more affordable, easy to use, and provides helpful reminders, alerts, and reports compared to conventional insulin. It helps calculate doses of the blood sugar level, carbohydrate amounts, meal size, and active insulin. In addition, it notifies the expiration date or exceeding the temperature range of insulin to replace the cartridge timely. As a result, smart insulin pen finds extensive applications in hospitals, clinics, ambulatory surgical centers, and home care units across the globe.

Smart Insulin Pens Market Trends:

At present, the growing awareness among the masses about the benefits of smart insulin pens, such as delivering accurate half-unit doses, preventing skipped or missed doses, and tracking time and number of doses, represents one of the key factors driving the market. Besides this, there is a rise in the prevalence of diabetes due to the increasing obesity and geriatric population across the globe. This, along with the burgeoning healthcare industry, is strengthening the growth of the market. In addition, key market players are extensively investing in research and development (R&D) activities to introduce smart insulin pens with memory and timing function that provides intelligent injection for patients. They are also focusing on developing Bluetooth-connected smart insulin pens. Moreover, there is an increase in the adoption of home treatment as it is more comfortable, convenient, and personalized. This, coupled with the escalating demand for needle-free insulin delivery devices due to the rising needle stick injuries while using, handling, disassembling, or disposing of needles, is bolstering the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global smart insulin pens market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on type, usability, indication, connectivity and end user.

Breakup by Type:

First Generation Pens

Second Generation Pens

Breakup by Usability:

Prefilled

Reusable

Breakup by Indication:

Type 1 Diabetes

Type 2 Diabetes

Breakup by Connectivity:

Bluetooth

USB

Breakup by End User:

Hospitals and Clinics

Ambulatory Surgical Centers

Home Care Settings

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Bigfoot Biomedical Inc., Digital Medics Pty Ltd., Emperra GmbH E-Health Technologies, Jiangsu Delfu Medical Device Co. Ltd., Medtronic plc, Novo Nordisk A/S, pendiq GmbH and Ypsomed AG.

Key Questions Answered in This Report

  • 1. What was the size of the global smart insulin pens market in 2023?
  • 2. What is the expected growth rate of the global smart insulin pens market during 2024-2032?
  • 3. What are the key factors driving the global smart insulin pens market?
  • 4. What has been the impact of COVID-19 on the global smart insulin pens market?
  • 5. What is the breakup of the global smart insulin pens market based on the type?
  • 6. What is the breakup of the global smart insulin pens market based on the usability?
  • 7. What is the breakup of the global smart insulin pens market based on the end user?
  • 8. What are the key regions in the global smart insulin pens market?
  • 9. Who are the key players/companies in the global smart insulin pens market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Smart Insulin Pens Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 First Generation Pens
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Second Generation Pens
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Usability

  • 7.1 Prefilled
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Reusable
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Indication

  • 8.1 Type 1 Diabetes
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Type 2 Diabetes
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Connectivity

  • 9.1 Bluetooth
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 USB
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by End User

  • 10.1 Hospitals and Clinics
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Ambulatory Surgical Centers
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Home Care Settings
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Bigfoot Biomedical Inc.
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
    • 16.3.2 Digital Medics Pty Ltd.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
    • 16.3.3 Emperra GmbH E-Health Technologies
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
    • 16.3.4 Jiangsu Delfu Medical Device Co. Ltd.
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 Medtronic plc
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
      • 16.3.5.4 SWOT Analysis
    • 16.3.6 Novo Nordisk A/S
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 Financials
      • 16.3.6.4 SWOT Analysis
    • 16.3.7 pendiq GmbH
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
    • 16.3.8 Ypsomed AG
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis